Terms ending in 2033
Every in-force patent on Confluent, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,092,427 | Alternating Circumferential Bridge Stent Design and Methods for Use Thereof In force · High confidence | Confluent Medical Technologies, Inc. | In force | High confidence | |
| US 9,168,227 | Multi-Encapsulated Microspheres Made with Oxidized Cellulose for In-Situ Reactions In force · High confidence | Covidien LP | In force | High confidence | |
| US 9,271,937 | Oxidized Cellulose Microspheres In force · Medium confidence | Covidien LP | In force | Medium confidence | |
| US 9,138,489 | Oxidized Cellulose Microspheres Including Visualization Agents In force · High confidence | Covidien LP | In force | High confidence | |
| US 9,447,196 | Dissolution of Oxidized Cellulose and Particle Preparation by Solvent and Non-Solvent Precipitation In force · High confidence | Covidien LP | In force | High confidence | |
| US 9,499,636 | Dissolution of Oxidized Cellulose and Particle Preparation by Cross-Linking With Multivalent Cations In force · High confidence | Covidien LP | In force | High confidence | |
| US 8,973,596 | Applicator Assembly with Integral Check-Valve In force · High confidence | Confluent Surgical, Inc. | In force | High confidence | |
| US 9,445,795 | Prevention Of Premature Gelling Of Delivery Devices For pH Dependent Forming Materials In force · High confidence | Confluent Surgical, Inc. | In force | High confidence | |
| US 10,040,871 | Medical Devices Based On Oxidized Cellulose In force · High confidence | Covidien LP | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Confluent, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.